The contribution of interleukin-13 and -15 to the cytokine network within normal and diseased gingiva

Journal of Periodontology

Volumn 78, Issue 4, 2007, Pages 691-695

  Johnson, Roger B ^a   Serio, Francis G ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Disease progression; Gingiva immunology; Gingivitis prevention and control; Interleukin 13; Interleukin 15; Interleukin 6; Periodontal diseases prevention and control

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 13; INTERLEUKIN 15;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; FEMALE; GINGIVA; GINGIVITIS; HUMAN; IMMUNOLOGY; MALE; PERIODONTITIS;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; FEMALE; GINGIVA; GINGIVITIS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-15; MALE; PERIODONTAL POCKET;

EID: 34247892211     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2007.060204     Document Type: Article

References (17)

1. Gemmell E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000 2004;35:21-41.
2. McInnes IB, al-Mughales J, Field M, et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996;2:175-182.
3. Carson WE, Giri JG, Lindemann MJ, et al. Interleukin (IL)- 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994; 180:1395-1400.
4. Giri JG, Ahdieh M, Eisenman J, et al. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL- 15. EMBO J 1994;13:2822-2829.
5. Lappin DF, MacLeod CP, Kerr A, Mitchell T, Kinane DF. Anti-inflammatory cytokine IL- 10 and T cell cytokine profile in periodontitis granulation tissue. Clin Exp Immunol 2001;123:294-300.
6. Zurawski G, deVries JE. Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994;15:19-26.
7. Fujihashi K, Yamamoto M, Hiroi T, et al. Selected Th1 and Th2 cytokine mRNA expression by CD4(+) T cells isolated from inflamed human gingival tissue. Clin Exp Immunol 1996;103:422-428.
8. Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new human lymphokine regulating inflammmatory immune responses. Nature 1993;362:248-250.
9. Johnson RB, Serio FG. Interleukin-18 concentrations and the pathogenesis of periodontal disease. J Periodontol 2005;76:785-790.
10. Dayan M, Segal R, Globerson A, et al. Effect of aging on cytokine production in normal and experimental lupus erythematosus-afflicted mice. Exp Gerontol 2000;35: 225-236.
11. American Academy of Periodontology. Parameter on chronic periodontitis with slight to moderate loss of periodontal support. J Periodontol 2001;71 (Suppl.): 853-855.
12. American Academy of Periodontology. Guidelines for the management of patients with periodontol diseases. J Periodontol 2006;77:1607-1611.
13. Johnson RB, Serio FG. Leptin within healthy and diseased human gingiva. J Periodontol 2001;72:1254-1257.
14. Johnson RB, Wood N, Serio FG. Interleukin-11 and IL- 17 and the pathogenesis of periodontal disease. J Periodontol 2004;75:37-43.
15. Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg 1998;22:382-389.
16. Mogi M, Otogoto J, Ota N, et al, Interleukin-1 beta, interleukin-6, beta 2-microglobulin, and transforming growth factor-alpha in gingival crevicular fluid from human periodontal disease. Arch Oral Biol 1999;44: 535-539.
17. McInnes IB, Gracie JA. Interleukin-15: A new cytokine target for the treatment of inflammatory diseases. Curr Opin Pharmacol 2004;4:392-397.